1. Home
  2. PAYC vs RGEN Comparison

PAYC vs RGEN Comparison

Compare PAYC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAYC
  • RGEN
  • Stock Information
  • Founded
  • PAYC 1998
  • RGEN 1981
  • Country
  • PAYC United States
  • RGEN United States
  • Employees
  • PAYC N/A
  • RGEN N/A
  • Industry
  • PAYC Computer Software: Prepackaged Software
  • RGEN Medical/Dental Instruments
  • Sector
  • PAYC Technology
  • RGEN Health Care
  • Exchange
  • PAYC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • PAYC 14.6B
  • RGEN 8.0B
  • IPO Year
  • PAYC 2014
  • RGEN N/A
  • Fundamental
  • Price
  • PAYC $227.89
  • RGEN $123.57
  • Analyst Decision
  • PAYC Hold
  • RGEN Buy
  • Analyst Count
  • PAYC 11
  • RGEN 12
  • Target Price
  • PAYC $230.00
  • RGEN $170.40
  • AVG Volume (30 Days)
  • PAYC 641.1K
  • RGEN 787.0K
  • Earning Date
  • PAYC 07-30-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • PAYC 0.65%
  • RGEN N/A
  • EPS Growth
  • PAYC N/A
  • RGEN N/A
  • EPS
  • PAYC 7.02
  • RGEN N/A
  • Revenue
  • PAYC $1,913,800,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • PAYC $10.03
  • RGEN $13.93
  • Revenue Next Year
  • PAYC $9.22
  • RGEN $14.35
  • P/E Ratio
  • PAYC $32.98
  • RGEN N/A
  • Revenue Growth
  • PAYC 9.87
  • RGEN 4.88
  • 52 Week Low
  • PAYC $139.50
  • RGEN $102.97
  • 52 Week High
  • PAYC $267.76
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • PAYC 34.05
  • RGEN 48.29
  • Support Level
  • PAYC $221.15
  • RGEN $115.86
  • Resistance Level
  • PAYC $235.46
  • RGEN $126.61
  • Average True Range (ATR)
  • PAYC 6.60
  • RGEN 4.43
  • MACD
  • PAYC -3.44
  • RGEN -0.07
  • Stochastic Oscillator
  • PAYC 13.67
  • RGEN 42.95

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: